Subcutaneous or Transvenous Defibrillator Therapy Reinoud E. Knops , Louise R.A. Olde Nordkamp , Peter-Paul H.M. Delnoy , Lucas V.A. Boersma , Jürgen Kuschyk , Mikhael F. El-Chami , Hendrik Bonnemeier , Elijah R. Behr , Tom F. Brouwer , Stefan Kääb , Suneet Mittal , Anne-Floor B.E. Quast , Lonneke Smeding , Willeke van der Stuijt , Anouk de Weger , Koen C. de Wilde , Nick R. Bijsterveld , Sergio Richter , Marc A. Brouwer , Joris R. de Groot , Kirsten M. Kooiman , Pier D. Lambiase , Petr Neuzil , Kevin Vernooy , Marco Alings , Tim R. Betts , Frank A.L.E. Bracke , Martin C. Burke , Jonas S.S.G. de Jong , David J. Wright , Jan G.P. Tijssen , Arthur A.M. Wilde New England Journal of Medicine（2020）
摘要
Abstract Background The subcutaneous implantable cardioverter–defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placemen...
更多 查看译文
AI 理解论文
溯源树
样例
